Disease-A-Month
Volume 53, Issue 5 , Pages 275-290 , May 2007

Sleep and Parkinson’s Disease

References 

  1. Dement W. History of sleep physiology and sleep medicine. In:  Kryger M,  Roth T,  Dement W editor. Principles and Practice of Sleep Medicine. Philadelphia, PA: WB Saunders; 2000;p. 1–14
  2. Shapiro CM, Dement WC. ABC of sleep disorders (Impact and epidemiology of sleep disorders). Br Med J. 1993;306(6892):1604–1607
  3. Thorpy MJ. Sleep disorders in Parkinson’s disease. Clin Cornerstone. 2004;6(suppl 1A):S7–S15
  4. Rye DB. Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med. 2004;5(3):317–328
  5. Rechtshaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute; 1968;
  6. Kushida C, Littner M, Morgenthaler T. Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep. 2005;28(4):499–521
  7. Michael R, Littner MR, Kushida C, et al. Standards of Practice Committee of the American Academy of Sleep Medicine Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test (An American Academy of Sleep Medicine Report). Sleep. 2005;28(1):113–121
  8. Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol. 1997;103(5):554–563
  9. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545
  10. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. JNNP. 2002;73:629–635
  11. Hobson DE, Lang AE, Martin WR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA. 2002;287(4):455–463
  12. National Sleep Foundation: http://www.sleepfoundation.org/atf/cf/{F6BF2668-A1B4-4FE8-8D1A-A5D39340D9CB}/SleepinessDiary2.pdf; accessed March 16, 2007.
  13. Hobson J. In: Sleep. New York, NY: Scientific American Library; 1995;p. 72
  14. Ohayon M, Carskadon M, Guilleminault C, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human life span. Sleep. 2004;27:1255–1273
  15. Bliwise D. Normal aging. In:  Kryger M,  Roth T,  Dement W editor. Principles and Practice of Sleep Medicine. Philadelphia, PA: WB Saunders; 2000;p. 26–42
  16. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES project. J Am Geriatr Soc. 1996;44(7):778–784
  17. Ondo W. Epidemiology of restless legs syndrome. Sleep Med. 2002;3(suppl 1):S13–S15
  18. Feinsilver SH. Sleep in the elderly (What is normal?). Clin Geriatr Med. 2003;19(1):177–188
  19. Bliwise DL, Watts RL, Watts N, et al. Disruptive nocturnal behavior in Parkinson’s disease and Alzheimer’s disease. J Geriatr Psychiatry Neurol. 1995;8(2):107–110
  20. Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson’s disease (A self-reported, community-based survey). Sleep Med. 2002;3(2):147–149
  21. Factor SA, McAlarney T, Sanchez-Ramos JR, et al. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord. 1990;5(4):280–285
  22. Macht M, Schwarz R, Ellgring H. Patterns of psychological problems in Parkinson’s disease. Acta Neurol Scand. 2005;111(2):95–101
  23. Arnulf I, Konofal E, Merino-Andreau M, et al. Parkinson’s disease and sleepiness: an integral part of PD. Neurology. 2002;58(7):1019–1024
  24. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson’s disease. Neurology. 2002;58(10):1544–1546
  25. Tan EK, Lum SY, Fook-Chong SM, et al. Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controls. Neurology. 2002;58(3):465–468
  26. Ondo WG, Dat Vuong K, Khan H, et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology. 2001;57(8):1392–1396
  27. Young A, Home M, Churchward T, et al. Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep. 2002;25(5):573–577
  28. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord. 1999;14(6):922–927
  29. Merino-Andreu M, Arnulf A, Konofal E, et al. Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness. Neurology. 2003;60(9):1553–1554
  30. Roth T, Rye DB, Borchert LD, et al. Assessment of sleepiness and unintended sleep in Parkinson’s disease patients taking dopamine agonists. Sleep Med. 2003;4(4):275–280
  31. Arnulf I, Bonnet AM, Damier P, et al. Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology. 2000;25(2):281–288
  32. Santamaria J. How to evaluate excessive daytime sleepiness in Parkinson’s disease. Neurology. 2004;26(suppl 3):S21–S23
  33. Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson’s disease. Mov Disord. 2000;15(2):212–215
  34. Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson’s disease: polysomnographic recordings. Mov Disord. 2001;16(3):500–506
  35. van Hilten B, Hoff JI, Middelkoop HA, et al. Sleep disruption in Parkinson’s disease (Assessment by continuous activity monitoring). Arch Neurol. 1994;51(9):922–928
  36. Brotini S, Gigli GL. Epidemiology and clinical features of sleep disorders in extrapyramidal disease. Sleep Med. 2004;5:169–179
  37. American Sleep Disorders Association. In: International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1997;p. 52–57
  38. American Sleep Disorders Association. In: International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1997;p. 57–61
  39. Braga-Neto P, da Silva FP, Sueli Monte F, et al. Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci. 2004;217:41–45
  40. Basta M. Sleep disordered breathing in patients with Parkinson’s disease. Respir Med. 2003;57:1151–1157
  41. Boissard R, Gervason D, Schmidt MH, et al. The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci. 2002;16(10):1959
  42. Jouvet M. Paradoxical sleep as a programming system. J Sleep Res. 1998;7(suppl 1):1–5
  43. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology. 2002;59(4):585–589
  44. American Sleep Disorders Association. In: International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1997;p. 177–180
  45. Schenck CS, Bundlie SR, Ettinger MG, et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9:293–308
  46. Comella C, Nardine T, Diedrich N, et al. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51:526–529
  47. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996;46:388–393
  48. Pappert EJ, Goetz CJ, Niederman FG, et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s Disease. Mov Disord. 1999;14(1):117–121
  49. Goetz CH, Wuu J, Curgian LM, et al. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology. 2005;64:81–85
  50. Manni R, Pacchetti C, Terzaghi M, et al. Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology. 2002;59(12):1979–1981
  51. Nomura T, Inoue Y, Mitani H, et al. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson’s disease. Mov Disord. 2003;18(7):812–817
  52. Ekbom KA. Restless legs syndrome. Neurology. 1960;10:868–873
  53. Allen RP, Picchietti D, Hening WA, et al. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health International Restless Legs Syndrome Study Group Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology (A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health). Sleep Med. 2003;4(2):101–119
  54. Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology. 2003;61(6):S49–S55(suppl 3).
  55. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002;59(3):421–424
  56. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. J Neurol Sci. 2002;196(1-2):33–36
  57. Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome. Sleep. 1998;21(4):371–377
  58. Phillips B. Movement disorders (A sleep specialist’s perspective). Neurology. 2004;62(suppl 2):s9–s16
  59. Lesage S, Wayne A, Hening WA. Restless legs syndrome and periodic limb movement disorder: a review of management. Semin Neurol. 2004;24:249–259
  60. Wetter TC, Collado-Seidel V, Pollmacher T, et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000;23(3):361–367
  61. Poewe W, Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson’s disease. Neurology. 2004;63(suppl 3):S12–S16
  62. American Sleep Disorders Association. In: International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1997;p. 65–68
  63. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 1999;52(9):1908–1910
  64. Homann CN, Wenzel K, Suppan K, et al. Sleep attacks in patients taking dopamine agonists: review. Br Med J. 2002;324(7352):1483–1487
  65. Padraig E, O’Suilleabhain PE, Dewey RB. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol. 2002;59(6):986–989
  66. Garcia-Borreguero D, Schwartz C, Larrosa O, et al. L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. J. Neurology. 2003;61(7):1008–1010
  67. Paus S, Brecht HM, Koster J, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord. 2003;18(6):659–667
  68. Arnulf I, Bejjani BP, Garma L, et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology. 2000;55(11):1732–1734
  69. Hjort N, Ostergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord. 2004;19(2):196–199
  70. Kedia S, Moro E, Tatliata M, et al. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology. 2004;63:2410–2412
  71. Eisensehr I, Lindeiner H, Jager M, et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography?. J Neurol Sci. 2001;186:7–11
  72. Iranzo A. The importance of sleep medicine consultation for diagnosis of REM sleep behavior disorder in most patients with Parkinson’s disease. Sleep Med. 2002;3(6):537–538
  73. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment guidelines. Neurology. 2001;56(suppl 5):s1–s88
  74. Comella CL. Daytime sleepiness, agonist therapy, and driving in Parkinson disease. J Am Med Assoc. 2002;287:509–511
  75. Hogl B, Saletu M, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep. 2002;25(8):905–909
  76. Adler CH, Caviness JN, Hentz JG, et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord. 2003;18(3):287–293
  77. Nieves AV, Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil. Clin Neuropharmacol. 2002;25(2):111–114
  78. Morin. Insomnia. Psychological Assessment and Management. New York, NY: Guilford Press, 1993.
  79. Reid KY, Zee PC. Circadian rhythm disorders. Semin Neurol. 2004;24:315–325
  80. Schenk C, Mahowald M. A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficiency in 89.5% of 57 treated patients. Clev Clin J Med. 1990;57(suppl):10–24
  81. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4:281–284
  82. Fantini M, Gagnon J, Filipini D, et al. The effects of pramipexole in REM sleep behavior disorder. Neurology. 2003;61:1418–1420
  83. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord. 996;2:214-6.
  84. Högl B, Rothdach A, Wetter TC, et al. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson’s disease. Neuropsychopharmacology. 2003;28(10):1866–1870
  85. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med. 2004;5:5–6
  86. Gordon P, Sanders MH. Sleep: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2005;60(1):68–75
  87. McDonald JP. A review of surgical treatment for obstructive sleep apnoea/hypopnoea syndrome. Surgeon. 2003;1(5):259–264
  88. Hoekema A, Stegenga B, de Bont LGM. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Crit Rev Oral Biol Med. 2004;15(3):137–155
  89. Guilleminault C, Robinson A. Central sleep apnea. Neurol Clin. 1996;14(3):611–628
  90. Moller JC, Stiasny K, Hargutt V, et al. Evaluation of sleep and driving performance in six patients with Parkinson’s disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord. 2002;17(3):474–481
  91. Brodsky MA, Godbold J, Roth T, et al. Sleepiness in Parkinson’s disease: a controlled study. Mov Disord. 2003;18:668–672
  92. Schlesinger I, Ravin PD. Dopamine agonists induce episodes of irresistible daytime sleepiness. Eur Neurol. 2003;49:30–33

PII: S0011-5029(07)00008-9

doi: 10.1016/j.disamonth.2007.02.005

Disease-A-Month
Volume 53, Issue 5 , Pages 275-290 , May 2007

Article Tools

* Image Usage & Resolution